Evaluation of Hedgehog Pathway Inhibition on Nevoid Basal Cell Carcinoma Syndrome Fibroblasts and Basal Cell Carcinoma-Associated Fibroblasts: Are Vismodegib and Sonidegib Useful to Target Cancer-Prone Fibroblasts?
Authors:
- Laura EibenschutzLELaura Eibenschutz
- Silvia CaputoSCSilvia Caputo
- Emanuela CameraECEmanuela Camera
- Anna CarboneACAnna Carbone
- Vitaliano SilipoVSVitaliano Silipo
- Emilia MiglianoEMEmilia Migliano
- Caterina AuriziCACaterina Aurizi
- Carlo CotaCCCarlo Cota
- Pasquale FrascionePFPasquale Frascione
- Barbara BelleiBBBarbara Bellei
Open Access
Abstract
Activating mutations in the Hh pathway underlies the development of sporadic and familial skin BCC. For these oncogenic proliferations displaying ligand-independent activation of the intracellular pathway, two molecules have been approved for therapeutic purposes: vismodegib and sonidegib. Improper Hh signalling occurs in many human tumours also via a paracrine mechanism (ligand-dependent) in which the secretion of Hh ligands by stromal cells support tumour growth. On the other hand, the mobilization of neoplastic stroma by cancer cells is sustained by the activation of Hh signalling in surrounding fibroblasts suggesting a central role of this bidirectional crosstalk in carcinogenesis. Additionally, loss-of-function mutations in the PTCH1 gene in the context of NBCCS, an autosomal dominant disorder predisposing to multiple BCCs, determine tumour permissive phenotypes in dermal fibroblasts. Here, profiling syndromic and BCC-associated fibroblasts unveiled an extraordinary similarity characterized by overexpression of several Hh target genes and a marked pro-inflammatory outline. Both cell types exposed to Hh inhibitors displayed reversion of the tumour-prone phenotype. Under vismodegib and sonidegib treatment, the Wnt/β-catenin pathway, frequently over-active in tumour stroma, resulted down-regulated by pAKT-GSK3β axis and consequent increase of β-catenin turnover. Overall, this study demonstrated that vismodegib and sonidegib impacting on fibroblast tumour supportive functions might be considered in therapy for BCC independently to the mutation status of Hh components in neoplastic cells.Keywords
Funding Information
- Ministero della Salute (2019-2020)
This publication has 113 references indexed in Scilit:
- The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significanceJournal of Translational Medicine, 2011
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- The Hedgehog's tale: developing strategies for targeting cancerNature Reviews Cancer, 2011
- Overexpression of Smoothened Activates the Sonic Hedgehog Signaling Pathway in Pancreatic Cancer–Associated FibroblastsClinical Cancer Research, 2010
- Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesisProceedings of the National Academy of Sciences, 2009
- Hedgehog signal transduction by Smoothened: Pharmacologic evidence for a 2-step activation processProceedings of the National Academy of Sciences, 2009
- Identification of the gene transcription repressor domain of Gli3FEBS Letters, 2008
- Nevoid basal cell carcinoma syndrome (Gorlin syndrome)Orphanet Journal of Rare Diseases, 2008
- Guidelines for the management of basal cell carcinomaBritish Journal of Dermatology, 2008
- Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathwaysProceedings of the National Academy of Sciences, 2007